Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study

AIMS: Reduced heart rate variability (HRV) and increased heart rate (HR) are associated with cardiovascular (CV) mortality. In the Liraglutide Effect and Action in Diabetes outcome trial, it was demonstrated a lower rate of CV events in type 2 diabetes (T2D) patients treated with liraglutide compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyström, Thomas, Santos‐Pardo, Irene, Fang, Xin, Cao, Yang, Hedberg, Fredric, Jendle, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458482/
https://www.ncbi.nlm.nih.gov/pubmed/31008366
http://dx.doi.org/10.1002/edm2.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458482/
https://www.ncbi.nlm.nih.gov/pubmed/31008366
http://dx.doi.org/10.1002/edm2.58

Ejemplares similares